PCR | real-time PCR | qPCR
new and forthcoming publications ...
Virology
new and forthcoming publications ...
Genome analysis | Biotechnology
new and forthcoming publications ...
Newsletter

Bacterial Therapeutics

Bacterial Therapeutics. A review of current scientific research, applications and resources.
Bifidobacteria
Edited by: Baltasar Mayo and Douwe van Sinderen
Leading bifidobacteria experts from around the world provide a state-of-the art overview of the molecular biology and genomics of this exciting and important microbial genus.
"essential reading for every bifidobacteria researcher" (Beneficial Microbes); "covers the topic of Bifidobacterium extensively" (Doodys); "essential reading" (BIOspektrum); "well-written, informative and uses high-quality graphics" (Microbiology Today) read more ...

Bacterial Therapeutics

Adapted from Parks et al. in Probiotics and Prebiotics: Scientific Aspects
Bacterial Therapeutics: The microbiota of the healthy human vagina is dominated by Lactobacillus species, which play an important role in protecting the host from urogenital infections. Disruption of the Lactobacillus-dominated microbiota can lead to abnormal vaginal microbial communities associated with bacterial vaginosis, and an increased incidence of urinary tract infection (UTI). In addition, epidemiological studies suggest that the normal vaginal microbial ecosystem may play a critical role in reducing the risk of sexually transmitted infections, including human immunodeficiency virus type 1 (HIV-1). Chapter 8 of Probiotics and Prebiotics: Scientific Aspects focuses on the role of lactobacilli in the vaginal ecosystem and the rational use of these bacteria as therapeutic agents for the treatment and prevention of urogenital infections.